| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.35 | 0.04 |